March 27, 2007
Glaxo Smith Kline Fined for Faulty Adertising
Posted at March 27, 2007 1:16 PM in .
A New Zealand court has fined pharma giant Glaxo Smith Kline for misleading advertising concerning its drink Ribena. The company had marketed the product as rich in vitamin C while two studies found no detectable vitamin C in the drink. This latest incident shows how big pharma's marketing practices can go beyond the ethical boundaries in order to sell a product.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/366 .